{"name":"Electra Therapeutics Inc.","slug":"electra-therapeutics-inc","ticker":"","exchange":"","domain":"electra.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxOeEVwaW9MR1BYNEJYZHRVSmJoUHhzaFVRRG1CeFlhdHpiU0JSRUFDaUlZWnpRZXhxZjZ2LUowMmQwYmtjX3JNVEZHVVI4M2JxYnd0Q0N1NHFPQnVacWZBUGU4aXNYR0NRbW9TNjZDc1JJTC1QWGVPak95R1JlTENLVU1hQUdScnQwZ3lfN3FRYTRaaGRrNnRnMWRSc3lsUUxPZS1PbGt4Mi1qdFJZTVVmQWdqOEhuaGItZ1ZPdw?oc=5","date":"2025-10-24","type":"pipeline","source":"The Business Journals","summary":"Electra Therapeutics snags $183 million to target inflammatory diseases - Bizwomen - The Business Journals","headline":"Electra Therapeutics snags $183 million to target inflammatory diseases - Bizwomen","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQZG43NFhiMGU1RXg3ZnhNMHJpb0FTLUhJenFhcDJHbkhpTzhyQXRidDFNbXZ0NEF0RjVxT1E4TkU5N0llWEZMeUJQRmN0WVBhR01sSGpEUUhGaWo4LW05c0tXT25YUUtBQ2VQOWI0eUV3NjMxR0FWUmN6ZENmVUJOWmFnTUtTdWdFUnpBdWNUaWtvZFNScURyQU8wVTBJcWgzQ0NCQXdwWQ?oc=5","date":"2025-10-22","type":"pipeline","source":"BioPharma Dive","summary":"Electra nabs $183M for its rare disease drug ambitions - BioPharma Dive","headline":"Electra nabs $183M for its rare disease drug ambitions","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPbU5rejFQdC1VcXRXNXNtTDRpNmtLbzdPcEVqc0RKbkVuUmpuemVQSzg2OFhfODgxaF9PamFic09qWVZwZzh1OFo3SVN1N2c3R0dpYU1LNlktb1dMWWlNZXdWZzBWOGctSDlfTVNqSm9NbnZEQW9XaGRYSjlGazc1SnZjU1ZueHdvb1VGUHNqel9QeTZXWExTUWpySVFBbWg2a240VzNpRQ?oc=5","date":"2025-10-22","type":"pipeline","source":"European Biotechnology Magazine","summary":"Electra Therapeutics raises US$183m in Series C financing - European Biotechnology Magazine","headline":"Electra Therapeutics raises US$183m in Series C financing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwJBVV95cUxPWXFXRmhYY2pXWllBVndwc2tGR19wS3NzTWJhdFM1X2cxVDZZVjVUZGhqOE9FUWVnSGhiN2p5b3owWHNRNTViREwtVlBfTFpfc3NvcDBvVnVieWMtT0lETzU4X0c2SGpkNG5mYUVMek5iS0NCbWY2RExDWEdlT2ZlNXprM1MwVHJ0b1NCLVZBOWdNUFlmbWxNWWJLb0NySy02VVp5VW1lVHVpb0o2OFZOd2VPYmtZVVd1Y3N4bUd0enY1ajlWenJUUEZPWFBTV0JDRDQzN1N2VUVIYWJIX0R0cFAwTEQ5aUJwZmdBUTd4ZTV6S3dTZ1JNRlZsaHBQenN5clNtVmt4dTRNczBEUDg2bVBwQVRTcHhnSVU2WllQcUktd29OYVVReU84WDQxTFJHTUpkcGpSZlhxREE?oc=5","date":"2025-10-22","type":"pipeline","source":"globenewswire.com","summary":"Electra Therapeutics Announces $183 Million Series C - globenewswire.com","headline":"Electra Therapeutics Announces $183 Million Series C","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxQaWVuMUpiTDNfYXVaOUJYdk5UWGx3aENhVWpqcTV5RThxd3JaSk1JN3ZjRDI5dVZldFBreWhDOHJhbU9za2xEOEtvaER2N255UlJzc09PcGNEb2ZyRmk5UUZ2dDhBX3hNYXFLdVJrbDZSc1dDUGgwTTQ2LURhekpBMnBkS2ZYNDVzQTVFd29sS0YzcUdYZXJwTmNZanA4RGJh?oc=5","date":"2025-10-15","type":"pipeline","source":"BioPharma Dive","summary":"A regenerative therapy for hair loss attracts a mega-fundraising round - BioPharma Dive","headline":"A regenerative therapy for hair loss attracts a mega-fundraising round","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxOeERsdnpXOU1MWmZEZ2lZWWZBdGlHazdoLWZnSTBPaUtKRjJqV1l1dHpfSDZRM05RYnloTTFvOUo0ZDRwRHdMTkZCWWpOeFVRa1FQeWFvWUt0bkd3R3RjRGliTVo5UEZFLXBkaDFzTHRFRS1ua2puWW11UG1CTWgxdTJtdm9LUm1MVDRCZUJVQ21iTVVrX18yVmh3LXMzUDYzd2t6UzZBMFhLZFlpMjYwNjNXRkdvaHU2V053SVpPbFc3S1dOVHc?oc=5","date":"2025-09-30","type":"pipeline","source":"Fierce Biotech","summary":"Star Therapeutics collects shiny $125M funding boost to push bleeding disorder prospect into orbit - Fierce Biotech","headline":"Star Therapeutics collects shiny $125M funding boost to push bleeding disorder prospect into orbit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNcU5DbE1HVXpfVVdCWkRUSUlNRkk2aHRPMF8yVHdWOXkzekxfRHlzODlfUGM3bVVHYllNaFdRNERRX2c1QlFQYkRPb201dkdhYkJXSHdNOXhvN2RZUlZMVjQ1MUFYUkVIdHlMd0pwTk9kWm8zVUM3Z2VER3VsclBIYl85dkRtSTBYSkFySQ?oc=5","date":"2025-09-30","type":"pipeline","source":"BioPharma Dive","summary":"Star raises another $125M for its blood disease drug - BioPharma Dive","headline":"Star raises another $125M for its blood disease drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxPNEd1QVYtdS1PdzJCMUNqS3c4c2NqVXdiRHZjbERKQ1pwSFpiUy1raHQ3RFdtQTR0NXM4ZTZlYzl5VEgxTnNiUy1DaDhldnd0TTRiRmJxNmYzZUtRYXEtZDlxWXZJUXY4VFhvT1oxM3R2Rlp2WmE1bzlad3dSQWxRZS04TkhubVplM0xrXzNIZDREZ0RoV1FmTE5jWDB6SW1PVmVpZmx4emJLS05ENXltSEJEV0R3Yk5LZWpxazMtSXltTWpjWmpGRjRvM0haOU44eFNuQUEyZWh5djhtSExjajdFNWRoZjhJU1M1N0MtNmx3WnR2TnNvRDdNT3B6ZmlfYWhrNFJCZjI4ZzJ2bGU2UmIyaV9zV1dRbzd2dW5BdWNkakcxRWZPYnhlRlVUbHVUYVdwRkw4RkVCOGJCUmtyeG94UEpRT3F2QzNuMlJHb0M1c21YZlpB?oc=5","date":"2024-12-09","type":"trial","source":"Business Wire","summary":"Electra Therapeutics Presents Positive Clinical Results From Completed Phase 1b Study of ELA026 in Secondary Hemophagocytic Lymphohistiocytosis (sHLH) in an Oral Session at ASH 2024 - Business Wire","headline":"Electra Therapeutics Presents Positive Clinical Results From Completed Phase 1b Study of ELA026 in Secondary Hemophagocy","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxQQ2N5dDJqU1FDaWVDdFBXdlhFSEh0Z3YtamJDclJmZUlpemM0TlUwUjhGeHJtcjBmWnRKRkl4QndWSWhQOV9ZSG5rMGNaUTg5d21BQ2d6TGpjd3pGU3JKOGhRNVVWclpGZzZNTGxrUmNieDhVeXF6eEJlQXNnMTlEdnhwMmVGWUt6bm9odzJ2MGVyM2gzMzRiOGx3?oc=5","date":"2023-12-13","type":"pipeline","source":"The Pharma Letter","summary":"Electra Therapeutics appoints new chief executive - The Pharma Letter","headline":"Electra Therapeutics appoints new chief executive","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNSVhycG1OYTlKOHJRdDNUTXh4djFqWjhBS25TZENzVndockRaeGpreVhjTjJmRG9LcXJQWWl2NVpGTHRhNlZFUFVvTEtTWDI0T185Rk5zTGt4eEhDQW5hMk5Eck9aNzB1NlJBOUtWTnotbm5LMHFnSWNodjFtYXY1LV9FaXZFRmRQbWV2cFFubWhkcVVHQm0wY2tTTlQ?oc=5","date":"2023-12-11","type":"pipeline","source":"Contract Pharma","summary":"Electra Therapeutics Names Kathy Dong President and CEO - Contract Pharma","headline":"Electra Therapeutics Names Kathy Dong President and CEO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPZmhGR0NVVEwteHg5RVh1OE5GNWxjUEZSWmJkRWVhenp4R1Jaa2NPcTNpZjV2WERtWGx4aGdqRGQ5MDlwT0I5MTAzeUs4M3lNLTEyX2lEYVhyd25mREhEcTZRaUVIR0hBSEEybHM2ZkxlLTlwTzhacHVmajFEQmpEWXB0bl9CSl81Wkh4U1E3M0JocW5RZ2dfSjRCT18?oc=5","date":"2022-02-16","type":"pipeline","source":"BioSpace","summary":"Star Therapeutics Starts a Family with Electra - BioSpace","headline":"Star Therapeutics Starts a Family with Electra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxOQVBYdTgybUtzcGtoc0RmZmF2TXZSVG51ZG82MjdMWkRoLWtyX1hXZEd3TDVkdXlpdEFTRTAtR3ZEdlFYZEZYdnJIak1wYVJKVVZ2SlZPUnNjRUw3b1dvendXcER4d1VlR2QyMmZPSnBoRnptS19TUGx2clp4M1htb3hFUXRKN2ZHd09mRVltVE84R3N1Qlk2bjhPRGRGTmF2Tk5vT3dtM01nUFltdDRQYTZSejhaY2I2YWVMZ2w2QS1fSHpJSkdHTEhZR21iU2Jpc1JNRjF6UzZoQTRRb0FoWDBvN2RLSVNkSGdpWXRrR05QLVhfUEpERktKRmpDY3JPdlgtVjNRWnY1RllTbGQ1MFhfMWM2Y19HUG5DWXFSdy13NlJFMk5BZERYQQ?oc=5","date":"2022-02-16","type":"pipeline","source":"Business Wire","summary":"Electra Therapeutics Announces $84 Million Series B Financing and Unveils Its Novel SIRP‑Targeted Therapies for Immunological Diseases and Cancer - Business Wire","headline":"Electra Therapeutics Announces $84 Million Series B Financing and Unveils Its Novel SIRP‑Targeted Therapies for Immunolo","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}